Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

232.36 +0.07 (+0.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

89 90 Next >

These 2 Dividend ETFs Are a Retiree's Best Friend ↗

Today 4:23 EST

Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.

Via The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

November 15, 2025

These stocks pay income that investors can count on over the long run.

Via The Motley Fool

Topics Intellectual Property

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 14, 2025

Via Benzinga

Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors? ↗

November 13, 2025

A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.

Via The Motley Fool

Topics ETFs Economy Retirement

What the Options Market Tells Us About AbbVie ↗

November 03, 2025

Via Benzinga

Looking Into AbbVie Inc's Recent Short Interest ↗

October 31, 2025

Via Benzinga

2 Strong Healthcare Stock Picks for Dividend Investors ↗

November 13, 2025

These top dividend payers could enrich a long-term investor's portfolio.

Via The Motley Fool

Topics Economy

AbbVie Shares Rise To Intraday High After Key Trading Signal ↗

November 12, 2025

A key trading signal flashed for AbbVie shares at a price of $228.47, after which ABBV rose as much as 2.4% to an intraday high of $233.90.

Via Benzinga

AbbVie Reportedly Ends Partnership With Alphabet-Backed Calico Life Sciences ↗

November 12, 2025

Stat News reported on Wednesday, citing internal emails, that the move comes amid AbbVie’s shift away from small-molecule drugs, including pills.

Via Stocktwits

Topics Workforce

Mixed Signals on Wall Street: Dow Soars Amidst Government Shutdown Hopes, Tech Giants Stumble

November 12, 2025

New York, NY – November 12, 2025 – The U.S. stock market presented a landscape of diverging fortunes today, as the Dow Jones Industrial Average surged to new record highs, fueled by mounting optimism...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

Dow Soars to All-Time Highs as Nation Awaits Crucial House Vote to End Government Shutdown

November 12, 2025

The Dow Jones Industrial Average (DJIA) has surged to unprecedented levels, marking new all-time highs this week, even as the nation holds its breath for a pivotal vote in the U.S. House of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Three Healthcare Buys That Wall Street Loves ↗

November 11, 2025

These three healthcare stocks are outperforming most of the sector.

Via The Motley Fool

5 Top Stocks to Buy in November ↗

November 11, 2025

All 5 stocks have upside potential heading into 2026.

Via The Motley Fool

Topics Economy

Chicago Fed's 7th District Hiring Expectations Crash to -40: A Dire Signal for the Economy and Fed Policy

November 10, 2025

The economic outlook for the U.S. Midwest has taken a concerning turn as the Chicago Federal Reserve's 7th District hiring expectations index reportedly plummeted to -40 in October 2025. This alarming...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill. ↗

November 09, 2025

Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.

Via The Motley Fool

Topics Stocks

Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now ↗

November 09, 2025

These stocks are priced low, have encouraging growth prospects, and also pay dividends.

Via The Motley Fool

The Top 5 Analyst Questions From AbbVie’s Q3 Earnings Call

November 07, 2025

AbbVie’s third quarter results were marked by strong year-on-year revenue growth, driven primarily by continued momentum in its immunology and neuroscience portfolios. Management pointed to sales...

Via StockStory

Topics Earnings

3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November ↗

November 06, 2025

These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on.

Via The Motley Fool

Topics Intellectual Property

US Economic Resilience Fuels Dollar's Ascent Amidst Global Shifts

November 05, 2025

The United States economy is currently riding a wave of positive momentum, with a series of robust economic indicators signaling underlying strength and resilience. This optimistic outlook has, in...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today ↗

November 05, 2025

Via Benzinga

Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients ↗

November 05, 2025

Linzess is the first treatment approved for the disease in pediatric patients, the FDA said.

Via Stocktwits

2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon ↗

November 04, 2025

Healthcare has been an extraordinarily resilient industry to put cash to work in through the years.

Via The Motley Fool

Topics Intellectual Property

ABBV Q3 Deep Dive: Immunology Growth and Pipeline Expansion Offset Margin Pressure

November 03, 2025

Pharmaceutical company AbbVie (NYSE:ABBV) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.1% year on year to $15.78 billion. Its non-GAAP profit of $1.86 per...

Via StockStory

My Favorite Dividend King to Buy in November ↗

November 03, 2025

This member of dividend royalty checks off lots of boxes for investors.

Via The Motley Fool

Topics Intellectual Property

2 Magnificent Dividend Stocks to Buy and Hold Forever ↗

November 02, 2025

Some might call them boring businesses, but they have tremendous dividend growth track records.

Via The Motley Fool

Topics Economy Intellectual Property

2 Top ETFs I Can't Wait to Buy More of in My Retirement Account This November ↗

November 02, 2025

These ETFs are ideal retirement holdings.

Via The Motley Fool

Topics ETFs Retirement Stocks

ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat ↗

November 01, 2025

Via MarketBeat

Why AbbVie Stock Flopped on Friday ↗

November 01, 2025

The market didn't exactly greet the company's latest earnings release with open arms.

Via The Motley Fool

Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout

October 31, 2025

Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...

Via MarketMinute

Topics Intellectual Property

Exploring the top movers within the S&P500 index during today's session. ↗

October 31, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AbbVie (NY:ABBV)

All News about AbbVie

Starting at $3.75/week.

Subscribe Today